Literature DB >> 20211751

Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.

Dong Wang1, Ying Wang, You-Ning Liu.   

Abstract

BACKGROUND: Bacterial infection has been considered the main cause of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). However, experimental model of COPD exacerbation induced by Haemophilus influenzae infection was not available up to now. Furthermore, only a few studies on evaluation of antibiotics using an H. influenzae infection model in mice have been reported. The aim of this work was to evaluate the activity of moxifloxacin on experimental pulmonary infection and colonization of H. influenzae in emphysematous hamsters.
METHODS: Pulmonary emphysema was developed by intratracheal instillation of porcine pancreatic elastase in golden hamsters, which were infected by agar-beads enclosing H. influenzae to establish animal models of AECOPD. Alterations of lung histopathology, inflammatory factor levels in plasma and bronchoalveolar lavage fluids (BALFs), viable cell counting of lung tissue were determined on different days after challenge and moxifloxacin administration.
RESULTS: Lung bacterial counts of BALFs and homogenates were significantly higher in emphysematous hamsters than those in normal non-emphysematous animals from 1 to 3 weeks after intratracheal inoculation of bacterial agar-beads suspensions. Moreover, H. influenzae colonized and survived for a longer period of time in emphysematous lungs than in normal non-emphysematous lungs after challenge. Efficacy of 3-day intragastric administration of moxifloxacin was proved by reduction in pulmonary H. influenzae burden and alleviation of inflammatory responses on days 4, 8 and 21 post-inoculation. No planktonic bacteria were isolated from BALFs in the first week after moxifloxacin treatment, and bacterial load in lung tissue homogenates declined significantly. Nevertheless, after 3 weeks, bacterial load in BALFs and homogenates of emphysematous lungs recovered to a large quantity. Inflammation in lung tissue, including lung consolidation, hemorrhage, and neutrophils infiltration, was conspicuously improved after administration of moxifloxacin. Levels of inflammatory factors in plasma were significantly decreased on days 8 and 21 after treatment compared with that without drug therapy. Inflammatory factors in BALF were also reduced, among which IL-8 dropped down markedly in early stage.
CONCLUSION: Our results suggest that chronic bacterial infection and colonization is highly correlated with lung emphysematous lesions, which would be one of the important mechanisms for repeated attacks of acute exacerbations of chronic pulmonary diseases and uncertain efficacies of antibiotics. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211751     DOI: 10.1016/j.pupt.2010.02.006

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  9 in total

1.  Emphysema induced by elastase enhances acute inflammatory pulmonary response to intraperitoneal LPS in rats.

Authors:  Lídia Maria Carneiro da Fonseca; Maycon Moura Reboredo; Leda Marília Fonseca Lucinda; Thaís Fernanda Fazza; Maria Aparecida Esteves Rabelo; Adenilson Souza Fonseca; Flavia de Paoli; Bruno Valle Pinheiro
Journal:  Int J Exp Pathol       Date:  2016-12-23       Impact factor: 1.925

2.  Pulmonary emphysema is associated with fungal sensitization in asthma.

Authors:  Yuta Kono; Masako To; Ryuta Tsuzuki; Satoshi Yamawaki; Seiko Soeda; Yasuo To
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

3.  Acute mechanical forces cause deterioration in lung structure and function in elastase-induced emphysema.

Authors:  M V Szabari; H Parameswaran; S Sato; Z Hantos; E Bartolák-Suki; B Suki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-03       Impact factor: 5.464

4.  Acute Lung Injury in Response to Intratracheal Instillation of Lipopolysaccharide in an Animal Model of Emphysema Induced by Elastase.

Authors:  Maria Aparecida Esteves Rabelo; Leda Marília Fonseca Lucinda; Maycon Moura Reboredo; Lídia Maria Carneiro da Fonseca; Fernando Fonseca Reis; Thaís Fernanda Fazza; Danielle Ribeiro Brega; Flavia de Paoli; Adenilson de Souza da Fonseca; Bruno Valle Pinheiro
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

5.  A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD.

Authors:  Aran Singanayagam; Nicholas Glanville; Ross P Walton; Julia Aniscenko; Rebecca M Pearson; James W Pinkerton; Jay C Horvat; Philip M Hansbro; Nathan W Bartlett; Sebastian L Johnston
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

6.  Proteomic differences with and without ozone-exposure in a smoking-induced emphysema lung model.

Authors:  Soo-Taek Uh; So-My Koo; An Soo Jang; Sung Woo Park; Jae Sung Choi; Yong-Hoon Kim; Choon Sik Park
Journal:  Korean J Intern Med       Date:  2014-12-30       Impact factor: 2.884

7.  Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid.

Authors:  Keisuke Naito; Kei Yamasaki; Kazuhiro Yatera; Kentaro Akata; Shingo Noguchi; Toshinori Kawanami; Kazumasa Fukuda; Takashi Kido; Hiroshi Ishimoto; Hiroshi Mukae
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-20

Review 8.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31

9.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.